Zai Lab Ltd (NAS:ZLAB)
$ 20.16 0.15 (0.75%) Market Cap: 1.98 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.57 GF Score: 71/100

Zai Lab Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 04:40PM GMT
Release Date Price: $151.32 (+2.08%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

(technical difficulty)

conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Matt Bannon and Tessa Romero from the team. Our next presenting company is Zai Lab and presenting on behalf of the company, we have CEO Samantha Du. Before I turn it over to Samantha, I just wanted to highlight to everyone listening on the webcast, if you'd like to submit a question, please use the Ask the Question feature in the portal, and I'm happy to ask the question on your behalf.

With that, I'll turn it over to Samantha.

Ying Du
Zai Lab Limited - Founder, Chairperson & CEO

Thank you, Anupam, for your introduction, and thanks JPM for hosting us today. Good morning, everyone, and thank you for attending Zai Lab session today. We appreciate your interest in Zai Lab and hope you and your loved ones are healthy and doing well in 2021.

Slide #2 is our safe harbor slide, which I won't burden you with all the details. Now let's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot